Akido Labs
Akido Labs is an AI-native care delivery company operating the Akido Care medical network across 96+ locations in California, Rhode Island, and New York, using its proprietary ScopeAI platform to deliver primary, specialty, and safety-net care to over 500,000 patients.
- Company typePrivate
- Founded2015
- HeadquartersLos Angeles, United States
- Headcount501–1,000
- GTM typeB2C
- OfferingServices
What Akido Labs does
Akido Labs is a Los Angeles-based, AI-native care delivery company founded in 2015 that operates an integrated medical network (the Akido Care network) spanning 96+ locations across California, Rhode Island, and New York, with 245 providers across 26 specialties serving more than 500,000 patients and 620,000 patient visits per year. Its foundational technology is ScopeAI, a proprietary clinical AI platform the company describes as 'the first AI operating system designed specifically for healthcare,' trained on what it calls the world's most powerful health data corpus and refined via reinforcement learning with human feedback (RLHF) from its in-network clinicians. ScopeAI is delivered to physicians through Akido Chart EMR, an in-house electronic medical record system that blends AI-generated diagnoses, treatment plans, and risk forecasts with clinician review, and is also deployed in field settings via tablets that enable community health workers to conduct AI-guided intakes for hard-to-reach populations.
Akido generates revenue primarily through fee-for-service and risk-bearing care contracts across commercial payers and government programs, including 100% Medi-Cal (California Medicaid) reimbursement for its street medicine and Enhanced Care Management (ECM) safety-net programs under CalAIM. The company's go-to-market combines direct care delivery (Akido Care clinics, mobile street-medicine units, Akido Medical in Brooklyn), channel partnerships (a JV with Rhode Island Primary Care Physicians Corporation, affiliation with Chaparral Medical Group), and targeted community programs (NYC ride-share driver mobile clinics, unhoused and substance-use-disorder populations in LA, Kern County, and the Bay Area). It has raised over $100M in cumulative venture funding, most recently a $60M Series B led by Oak HC/FT in May 2025, and reports 300% year-over-year run-rate growth into mid-nine figures as of January 2026. Strategic leadership additions in early 2026 (Matt Siegler as Chief Network Officer, Jack Greco on the board) and academic partnerships with Caltech's Merkin Institute and USC's Keck School of Medicine support a stated goal of national expansion in 2026.
Akido Labs firmographics
Firmographics- Name
- Akido Labs
- Legal name
- Akido Labs, Inc.
- Website
- https://akidolabs.com
- Company type
- Private
- Founded year
- 2015
- Operating status
- Operating
- Headcount range
- 501–1,000 employees
- Short description
- Akido Labs is an AI-native care delivery company operating the Akido Care medical network across 96+ locations in California, Rhode Island, and New York, using its proprietary ScopeAI platform to deliver primary, specialty, and safety-net care to over 500,000 patients.
- Ownership category
- akta.pro rank
Akido Labs industry classification
Industry- Product category
- AI-Enabled Healthcare Delivery
- NAICS
- Medical and Diagnostic Laboratories (62151)
- SIC
- Services-Offices & Clinics Of Doctors Of Medicine (8011)
- akta.pro primary industry
- EHR Extensions, APIs, App Marketplaces & SMART-on-FHIR Apps (HLACAAAN)
- akta.pro secondary industry
- Post-Acute Care Networks & Care Management Organizations (HLAFAFAN)
Keywords
Where Akido Labs is headquartered
LocationHeadquarters
- HQ city
- Los Angeles
- HQ country
- United States
- HQ region
- North America
Offices4 records
Markets served
Akido Labs business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Operations, Infrastructure, Marketing or Sales
Revenue model
- Patient Care Services (Akido Care): Direct healthcare delivery through the Akido Care medical network of 96+ locations across primary care and 26 specialties; 620,000 patient visits per year generating service revenue across commercial and government payers.
- Medi-Cal Reimbursements (Safety Net Programs): 100% of street medicine and Enhanced Care Management program costs are covered by Medi-Cal (California Medicaid) reimbursements, including services under the CalAIM Medicaid program.
- Risk-Bearing Care Models: Akido operates risk-bearing care models as an AI-native health system, taking financial accountability for patient outcomes; the company is seeing 300% growth into mid-nine figures run rate.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | — | Medi-Cal-covered safety net services (Street Medicine, Enhanced Care Management) |
Go-to-market motion4 records
Distribution channels6 records
Marketing channels7 records
Akido Labs product offering
Product offeringCore offering
Akido Labs operates an AI-native health system that combines its proprietary ScopeAI clinical intelligence platform with a directly operated medical network (Akido Care) of 96+ locations and 245 providers across 26 specialties. ScopeAI delivers streamlined diagnosis, optimized diagnostics, personalized treatment planning, and forecasted health risk predictions, embedded within the Akido Chart EMR and refined via RLHF from Akido's clinicians. Patient-facing services include primary care, specialty care, and safety-net programs such as Street Medicine and Enhanced Care Management, serving 500,000+ patients across California, Rhode Island, and New York.
Product overview
Akido Labs operates a single integrated offering composed of a core AI platform delivered through a medical network, rather than a set of standalone products. The centerpiece is Scope AI — Akido's proprietary clinical AI operating system, which is delivered to clinicians through Akido Chart EMR. Scope AI powers all clinical workflows across the Akido Care medical network, which spans 96+ locations, 240+ providers across 26 specialties, and more than 500,000 patients across California, Rhode Island, and New York. Akido Care is organized into three service lines: Primary Care, Specialty Care, and Safety Net Services (which include the Street Medicine program launched in 2023 and Enhanced Care Management). New York operations are branded Akido Medical. The Street Medicine program is the most prominent real-world deployment of Scope AI, using AI-guided intake and investigation on tablets to enable community health workers and field medical assistants to extend licensed-provider reach into street, field, and remote settings, including the Bay Area launch announced in January 2026. The Scope AI / Akido Care combination is additionally governed by the AI Collaborative, an AI ethics council Akido formed with Caltech's Merkin Institute and the Keck School of Medicine of USC Department of Surgery in August 2024.
Differentiator
Problem solved
Functional benefit
Brands
- Akido Care: Akido's primary care and specialty care medical network offering primary care, specialty care, and safety-net services (including street medicine and enhanced care management) across California, Rhode Island, and New York.
- Scope AI
- Akido Medical
Products and services
- Scope AI
Quantifiable outcome
- 53% of patients see a medical provider on their first day of engagement in street medicine programs
- +12 more outcomes
Companies that use Akido Labs
Customer profileSegments4 records
Ideal customer profiles4 records
Akido Labs technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability9 records
Feature6 records
Akido Labs partnerships and signals
Strategic signalScale indicators12 records
Recent moves8 records
Expansion highlights7 records
Akido Labs competitors and assessment
Company assessmentDirect peers
- Cityblock Health: Value-based primary care company focused on Medicaid and dual-eligible populations with a tech-enabled care model and street/community outreach. Directly comparable to Akido in target population, payer mix, and tech-augmented care delivery approach.
- Oak Street Health (CVS Health): Risk-bearing, value-based primary care provider for complex Medicare and Medicaid populations; acquired by CVS Health for ~$10.6B. Comparable in risk-bearing model, complex-population focus, and tech-enabled workflow though primarily senior-focused.
- One Medical (Amazon): Tech-enabled primary care platform combining owned clinics with a digital app for membership-based care; acquired by Amazon for ~$3.9B. Comparable in the AI/tech-augmented primary care thesis and clinic-plus-platform distribution, though originally commercial-insurance focused.
- ChenMed: Family-owned, value-based primary care group serving low-income seniors with complex chronic conditions under full risk. Comparable in operating owned clinics, taking risk on outcomes, and serving high-acuity populations — though without Akido's AI platform layer.
- Carbon Health: Tech-enabled primary and urgent care provider operating multi-state clinics with proprietary EHR and AI-assisted documentation. Comparable in AI-augmented primary care delivery and clinic-plus-platform model, though more commercially focused.
Emerging players
- Forward Health: AI-powered preventive primary care membership clinics with proprietary technology for diagnostics and care planning. Comparable in the AI-native care delivery thesis and emphasis on ScopeAI-like operating-system framing, though focused on preventive rather than safety-net care.
- Aledade: Value-based care enablement platform that partners with independent primary care practices to take risk in Medicare, Medicaid, and ACA. Comparable in risk-bearing care economics and focus on community-based providers, but does not own clinics or operate AI like ScopeAI.
- Babylon Health: Pioneer in AI-driven primary care triage, virtual care, and population health analytics with an AI clinical reasoning engine. Comparable in the AI-first operating system framing for primary care, though Babylon's business model centered on virtual-only care and it largely exited US markets.
Broad incumbents
- Clover Health: Medicare Advantage insurer with proprietary Clover Assistant AI software deployed into primary care workflows to drive value-based outcomes. Comparable in combining an AI clinical assistant with risk-bearing payer/provider economics, though Clover is primarily a payer.
- Kaiser Permanente: Integrated payer-provider system operating owned clinics, hospitals, and health plan across multiple states with deep value-based care infrastructure. Akido's Head of Healthcare Networks (Leslie Margolin) is a former National COO of Kaiser; comparable as the dominant incumbent in integrated, risk-bearing care Akido is attempting to disrupt.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks7 records
Key highlights7 records
Customer concentration
Akido Labs social profiles
Digital presenceAkido Labs compliance and trust
Trust signalCompliance3 records
Akido Labs financial estimates
Financial estimateRevenue estimate
Valuation estimate
Akido Labs leadership team
Management profileNumber of profiles
Profiles12 records
Akido Labs subsidiaries and ownership
Company hierarchySubsidiaries2 records
Akido Labs funding detail
Funding detailFunding overview
Funding rounds8 records
Investors21 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Akido Labs M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Akido Labs
What does Akido Labs do?
Akido Labs operates an AI-native health system that combines its proprietary ScopeAI clinical intelligence platform with a directly operated medical network (Akido Care) of 96+ locations and 245 providers across 26 specialties. ScopeAI delivers streamlined diagnosis, optimized diagnostics, personalized treatment planning, and forecasted health risk predictions, embedded within the Akido Chart EMR and refined via RLHF from Akido's clinicians. Patient-facing services include primary care, specialty care, and safety-net programs such as Street Medicine and Enhanced Care Management, serving 500,000+ patients across California, Rhode Island, and New York.
Is Akido Labs a public or private company?
Akido Labs is a private company. It is classified as venture growth investor backed and is currently operating.
When was Akido Labs founded?
Akido Labs was founded in 2015. It employs 501 to 1,000 people.
Where is Akido Labs based?
Akido Labs is headquartered in Los Angeles, United States, in the North America region.
How does Akido Labs make money?
Three revenue lines are on record. Patient Care Services (Akido Care) is the primary driver. The others are medi-Cal Reimbursements (Safety Net Programs) and risk-Bearing Care Models.
Who are Akido Labs's main competitors?
Direct peers on record are Cityblock Health, Oak Street Health (CVS Health), One Medical (Amazon), ChenMed and Carbon Health. Emerging players are Forward Health, Aledade and Babylon Health. Broad incumbents are Clover Health and Kaiser Permanente.
Does Akido Labs have an API?
No public API is recorded for Akido Labs.
What industry is Akido Labs in?
Akido Labs's product category is AI-Enabled Healthcare Delivery. Its primary akta.pro industry code is HLACAAAN, EHR Extensions, APIs, App Marketplaces & SMART-on-FHIR Apps, with a secondary code of HLAFAFAN, Post-Acute Care Networks & Care Management Organizations. Its NAICS code is 62151 and its SIC code is 8011.